Xiaowen Tang
Qingdao University(CN)Peking University(CN)Soochow University(CN)Peking University People's Hospital(CN)National Clinical Research(US)Shanghai Traditional Chinese Medicine Hospital(CN)Nanopolis Suzhou (China)(CN)First Affiliated Hospital of Soochow University(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.(2018)
- → The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update(2021)299 cited
- → Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss(2010)138 cited
- → CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation(2021)117 cited
- → Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation(2009)116 cited
- → Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update(2024)111 cited